Diaceutics (DXRX)

Sector:

Health Care

Index:

FTSE AIM All-Share

0.000p
   
  • Closing Price Chg:
      4.00p
  • 52 Week High: 168.00p
  • 52 Week Low: 108.00p
  • Currency: UK Pounds
  • Shares Issued: 84.90m
  • Volume: 0
  • RiskGrade: 196
  • Beta: 0.40

Financial Analysis

Select chart: EPS | Dividend | Revenue

Latest Interim/Quarterly

Period Ending Period Revenue (£m) Pre-tax (£m) EPS Dividend
30-Jun-25 Interim 14.56 (3.01) (2.84)p n/a

Key Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 12.70 (0.68) 0.74p 180.4 n/a -70% n/a 0.0%
31-Dec-21 13.94 0.46 0.67p 152.2 n/a -10% n/a 0.0%
31-Dec-22 19.50 0.56 0.86p 87.8 3.1 +28% n/a 0.0%
31-Dec-23 23.70 (2.44) (2.07)p n/a n/a n/a n/a 0.0%
31-Dec-24 32.16 (1.91) (2.02)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Forecasts data is not available for this company.

Copyright © 2026 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest 180.41 n/a 63.26 0

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

Diaceutics Market Data

Currency UK Pounds
Share Price 160.00p
Closing Price Change 4.00p
% Change 0.00 %
52 Week High 168.00p
52 Week Low 108.00p
Volume 0
Shares Issued 84.90m
Beta 0.40
RiskGrade 196

Diaceutics Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
33.57% below the market average33.57% below the market average33.57% below the market average33.57% below the market average33.57% below the market average
51.52% below the sector average51.52% below the sector average51.52% below the sector average51.52% below the sector average51.52% below the sector average
Price Trend
29.40% above the market average29.40% above the market average29.40% above the market average29.40% above the market average29.40% above the market average
60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average
Income Not Available
Growth
48.02% above the market average48.02% above the market average48.02% above the market average48.02% above the market average48.02% above the market average
54.29% above the sector average54.29% above the sector average54.29% above the sector average54.29% above the sector average54.29% above the sector average

Diaceutics Dividends

No dividends found

Trades for 19-Jan-2026

Time Volume / Share Price
15:53 5,000 @ 158.63p
15:53 1,253 @ 159.50p
15:24 5,600 @ 158.77p
13:11 200 @ 158.63p
12:02 1,247 @ 159.94p

Diaceutics Key Personnel

CEO Ryan Gerard Keeling
CFO Nick Roberts

Top of Page